Mission Thrombectomy is an outreach initiative aimed at increasing access to stroke care globally.
There is a gap, globally, in availability of mechanical thrombectomy. 4 main factors in this disparity, especially in low and middle income countries are out of pocket expenditure and limited insurance reimbursement, availability of mechanical thrombectomy therapy, mostly in the private sector, the tremendous inequity in the low and middle income countries, and poor knowledge of stroke symptoms amongst patients and communities.
To address this global gap with UN and WHO for the recognition of Mechanical Thrombectomy as an essential surgery requires both a bottom-up and top-down approach, both of which serve as the foundation of our work.
The Neglected Pandemic
The numbers that describe Large Vessel Occlusion stroke are staggering.
- Globally 13.7 million ( 137 lakh) Strokes/year
- 9.5 million (95 lakh) Ischemic strokes/ year
- 5.2 Million Stroke Related Deaths in 2017
- 116 million healthy years of life lost due to stroke/ year
- Developing countries have
- 75% of all stroke deaths
- 81% of total (DALYs)
Source: Neuroepidemiology 2015;45:161–176 DOI: 10.1159/000441085
The Access Gap
In 2012, Zaidat et al1 estimated LVO to be 4% to 14% of the total of 675,000 ischemic strokes in the US
- Thus, MT eligible patients is the US may range from 27,000 to 97,000 patients annually
- Other estimates of LVOs are approximately 9% to 27% of the total, yielding estimates of 60,750 to 182,250 total LVO in the US
- Total MTs in USA estimated in 2016 was estimated to be under 20,000, a large gap between the need and MT performed.
- Worldwide estimate of 10% LVO yields a staggering 1.3M LVO annually
- Total MTs worldwide:
- 2016: <100,000
- 2020: ~200,000